Copyright Reports & Markets. All rights reserved.

Parkinson’s Disease Treatment -Global Market Status and Trend Report 2013-2023

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Parkinson’s Disease Treatment

    • 1.1 Definition of Parkinson’s Disease Treatment in This Report
    • 1.2 Commercial Types of Parkinson’s Disease Treatment
      • 1.2.1 Oral
      • 1.2.2 Transdermal
      • 1.2.3 Subcutaneous
      • 1.2.4 Intestinal Infusion
    • 1.3 Downstream Application of Parkinson’s Disease Treatment
      • 1.3.1 Hospital Pharmacy
      • 1.3.2 Retail Pharmacy
      • 1.3.3 Online Pharmacy
    • 1.4 Development History of Parkinson’s Disease Treatment
    • 1.5 Market Status and Trend of Parkinson’s Disease Treatment 2013-2023
      • 1.5.1 Global Parkinson’s Disease Treatment Market Status and Trend 2013-2023
      • 1.5.2 Regional Parkinson’s Disease Treatment Market Status and Trend 2013-2023

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Parkinson’s Disease Treatment 2013-2017
    • 2.2 Production Market of Parkinson’s Disease Treatment by Regions
      • 2.2.1 Production Volume of Parkinson’s Disease Treatment by Regions
      • 2.2.2 Production Value of Parkinson’s Disease Treatment by Regions
    • 2.3 Demand Market of Parkinson’s Disease Treatment by Regions
    • 2.4 Production and Demand Status of Parkinson’s Disease Treatment by Regions
      • 2.4.1 Production and Demand Status of Parkinson’s Disease Treatment by Regions 2013-2017
      • 2.4.2 Import and Export Status of Parkinson’s Disease Treatment by Regions 2013-2017

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Parkinson’s Disease Treatment by Types
    • 3.2 Production Value of Parkinson’s Disease Treatment by Types
    • 3.3 Market Forecast of Parkinson’s Disease Treatment by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Parkinson’s Disease Treatment by Downstream Industry
    • 4.2 Market Forecast of Parkinson’s Disease Treatment by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Parkinson’s Disease Treatment

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Parkinson’s Disease Treatment Downstream Industry Situation and Trend Overview

    Chapter 6 Parkinson’s Disease Treatment Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Parkinson’s Disease Treatment by Major Manufacturers
    • 6.2 Production Value of Parkinson’s Disease Treatment by Major Manufacturers
    • 6.3 Basic Information of Parkinson’s Disease Treatment by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Parkinson’s Disease Treatment Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Parkinson’s Disease Treatment Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Parkinson’s Disease Treatment Major Manufacturers Introduction and Market Data

    • 7.1 UCB
      • 7.1.1 Company profile
      • 7.1.2 Representative Parkinson’s Disease Treatment Product
      • 7.1.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of UCB
    • 7.2 AbbVie
      • 7.2.1 Company profile
      • 7.2.2 Representative Parkinson’s Disease Treatment Product
      • 7.2.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of AbbVie
    • 7.3 Acorda Therapeutics
      • 7.3.1 Company profile
      • 7.3.2 Representative Parkinson’s Disease Treatment Product
      • 7.3.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Acorda Therapeutics
    • 7.4 Roche
      • 7.4.1 Company profile
      • 7.4.2 Representative Parkinson’s Disease Treatment Product
      • 7.4.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Roche
    • 7.5 Teva
      • 7.5.1 Company profile
      • 7.5.2 Representative Parkinson’s Disease Treatment Product
      • 7.5.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Teva
    • 7.6 Prothena
      • 7.6.1 Company profile
      • 7.6.2 Representative Parkinson’s Disease Treatment Product
      • 7.6.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Prothena
    • 7.7 Orion Pharmaceuticals
      • 7.7.1 Company profile
      • 7.7.2 Representative Parkinson’s Disease Treatment Product
      • 7.7.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Orion Pharmaceuticals
    • 7.8 Impax Pharmaceuticals
      • 7.8.1 Company profile
      • 7.8.2 Representative Parkinson’s Disease Treatment Product
      • 7.8.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Impax Pharmaceuticals
    • 7.9 Voyager Therapeutics
      • 7.9.1 Company profile
      • 7.9.2 Representative Parkinson’s Disease Treatment Product
      • 7.9.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Voyager Therapeutics
    • 7.10 MSD
      • 7.10.1 Company profile
      • 7.10.2 Representative Parkinson’s Disease Treatment Product
      • 7.10.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of MSD
    • 7.11 Sunovion
      • 7.11.1 Company profile
      • 7.11.2 Representative Parkinson’s Disease Treatment Product
      • 7.11.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Sunovion
    • 7.12 Intec Pharma
      • 7.12.1 Company profile
      • 7.12.2 Representative Parkinson’s Disease Treatment Product
      • 7.12.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Intec Pharma
    • 7.13 GSK
      • 7.13.1 Company profile
      • 7.13.2 Representative Parkinson’s Disease Treatment Product
      • 7.13.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of GSK
    • 7.14 Acadia
      • 7.14.1 Company profile
      • 7.14.2 Representative Parkinson’s Disease Treatment Product
      • 7.14.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of Acadia
    • 7.15 NeuroDerm
      • 7.15.1 Company profile
      • 7.15.2 Representative Parkinson’s Disease Treatment Product
      • 7.15.3 Parkinson’s Disease Treatment Sales, Revenue, Price and Gross Margin of NeuroDerm
    • 7.16 Adamas Therapeutics

    Chapter 8 Upstream and Downstream Market Analysis of Parkinson’s Disease Treatment

    • 8.1 Industry Chain of Parkinson’s Disease Treatment
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Parkinson’s Disease Treatment

    • 9.1 Cost Structure Analysis of Parkinson’s Disease Treatment
    • 9.2 Raw Materials Cost Analysis of Parkinson’s Disease Treatment
    • 9.3 Labor Cost Analysis of Parkinson’s Disease Treatment
    • 9.4 Manufacturing Expenses Analysis of Parkinson’s Disease Treatment

    Chapter 10 Marketing Status Analysis of Parkinson’s Disease Treatment

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Parkinson’s Disease Treatment -Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Parkinson’s Disease Treatment industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Parkinson’s Disease Treatment 2013-2017, and development forecast 2018-2023
      Main manufacturers/suppliers of Parkinson’s Disease Treatment worldwide, with company and product introduction, position in the Parkinson’s Disease Treatment market
      Market status and development trend of Parkinson’s Disease Treatment by types and applications
      Cost and profit status of Parkinson’s Disease Treatment , and marketing status
      Market growth drivers and challenges

      The report segments the global Parkinson’s Disease Treatment market as:

      Global Parkinson’s Disease Treatment Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Parkinson’s Disease Treatment Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
      Oral
      Transdermal
      Subcutaneous
      Intestinal Infusion

      Global Parkinson’s Disease Treatment Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
      Hospital Pharmacy
      Retail Pharmacy
      Online Pharmacy

      Global Parkinson’s Disease Treatment Market: Manufacturers Segment Analysis (Company and Product introduction, Parkinson’s Disease Treatment Sales Volume, Revenue, Price and Gross Margin):
      UCB
      AbbVie
      Acorda Therapeutics
      Roche
      Teva
      Prothena
      Orion Pharmaceuticals
      Impax Pharmaceuticals
      Voyager Therapeutics
      MSD
      Sunovion
      Intec Pharma
      GSK
      Acadia
      NeuroDerm
      Adamas Therapeutics

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now